| Stereochemistry | ACHIRAL |
| Molecular Formula | C8H5N3O3S2 |
| Molecular Weight | 255.274 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[O-][N+](=O)C1=CN=C(NC(=O)C2=CC=CS2)S1
InChI
InChIKey=ZLOXYEZYWCTXHU-UHFFFAOYSA-N
InChI=1S/C8H5N3O3S2/c12-7(5-2-1-3-15-5)10-8-9-4-6(16-8)11(13)14/h1-4H,(H,9,10,12)
| Molecular Formula | C8H5N3O3S2 |
| Molecular Weight | 255.274 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Originator
Approval Year
PubMed
Patents
Sample Use Guides
Urogenital trichomoniasis treatment: The usual dose is 1 capsule in the morning and 1 capsule (250 mg) in the evening during meals, for 4 days. Both partners should be treated simultaneously.
Route of Administration:
Oral
